Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VIVIMEDLAB.NSthis companyVivimed Labs Ltd.	₹5.40	-0.26×	-0.22×	0.66×	-3.03×	-1194.8%	-78.3%	-255.0%	-252.1%	83.8%	-28.3%	14.7%	-1.89×	-2.71×	-42.8×	0.37×	0.0%	3	-1.08	2	C
CBPL.BOChandra Bhagat Pharma Limited	₹57.85	7.57×	0.7×	0.2×	5.11×	-988.0%	19.5%	2.4%	2.6%	9.2%	4.1%	36.0%	0.5×	1.88×	1.38×	1.5×	0.0%	6	2.14	3	B+
Peer median	—	7.57×	0.7×	0.2×	5.11×	-988.0%	19.5%	2.4%	2.6%	9.2%	4.1%	36.0%	0.5×	1.88×	1.38×	1.5×	0.0%	6	2.14	3	—